Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke

NCT05292625 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Vinmec Research Institute of Stem Cell and Gene Technology